Description
Description: Lenvima 4 mg Capsules are a potent medication manufactured by Eisai Co., Ltd. Each capsule contains 4 milligrams (mg) of the active ingredient Lenvatinib. This medication belongs to the class of receptor tyrosine kinase inhibitors and is used in the treatment of certain types of cancer.
Active Ingredient: The active ingredient in Lenvima is Lenvatinib. Lenvatinib works by inhibiting the activity of specific receptors on cancer cells, including vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR). By blocking these receptors, Lenvatinib helps to slow down the growth and spread of cancer cells.
Manufacturer: Lenvima 4 mg Capsules are manufactured by Eisai Co., Ltd., a leading pharmaceutical company committed to improving global healthcare through innovative research and development. Eisai Co., Ltd. is known for its dedication to addressing unmet medical needs and improving patient outcomes.
Uses: Lenvima 4 mg Capsules are indicated for the treatment of several types of cancer, including:
- Differentiated thyroid cancer (DTC) that is either locally recurrent or metastatic, refractory to radioactive iodine.
- Advanced renal cell carcinoma (RCC) after one prior anti-angiogenic therapy.
- Unresectable hepatocellular carcinoma (HCC).
How to Use: Lenvima 4 mg Capsules should be taken orally, usually once daily with or without food, as directed by a healthcare professional. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer being treated, as well as the patient’s overall health and response to therapy. It is essential to swallow the capsules whole with a glass of water and not to crush, chew, or open them.
Storage Conditions: Lenvima 4 mg Capsules should be stored according to the manufacturer’s instructions, typically at room temperature away from heat, light, and moisture. The capsules should be kept in their original packaging and out of reach of children and pets.
Precautions:
- Lenvima 4 mg Capsules should be used with caution in patients with certain medical conditions, such as hypertension, cardiac dysfunction, and proteinuria.
- Regular monitoring of blood pressure, thyroid function, liver function, and renal function is recommended during treatment with Lenvima.
- It is essential to inform the healthcare provider about any medications, supplements, or herbal products being taken before starting treatment with Lenvima.
Contraindications: Lenvima 4 mg Capsules are contraindicated in patients with a known hypersensitivity to Lenvatinib or any of the components in the formulation. It should not be used in pregnant or breastfeeding women due to the potential risk of harm to the fetus or nursing infant.
Side Effects: Common side effects associated with Lenvima 4 mg Capsules may include hypertension, fatigue, diarrhea, decreased appetite, weight loss, and nausea. More severe side effects, such as thromboembolism, cardiac events, hepatotoxicity, and renal failure, are possible but less common. Promptly report any unusual or severe symptoms to a healthcare provider.
Reviews
There are no reviews yet.